fbpx

David Sharek

David Sharek is stock portfolio manager at Shareks Stock Portfolios and the founder of The School of Hard Stocks. Sharek's Growth Stock Portfolio has delivered its investors an average return of 18% per year since inception vs. the S&P 500's 10% during that time (2003-2020). David's delivered five years of +40% returns in his 18 year career, including 106% during 2020. David Sharek's book The School of Hard Stocks can be found on Amazon.com.

10% SSS Can’t Last

Vitamin Shoppe (VSI) is doing well becasue same store is strong. Still, I feel this stock is fully valued and people should invest in GNC (GNC) instead.

Top Stocks Weak Due to Tax Selling

Some top stocks for 2012 are acting weak because investors are selling before taxes rise in 2013. But selling a stock down 20% isn’t worth saving 5% of gains.

Tremendously Undervalued

Express Scripts (ESRX) is a conservative stock with little downside risk that is tremendously undervalued right now. ESRX is one of my top picks for 2013.

Dissing Priceline

Everybody keeps dissing Priceline.com (PCLN). The stock has a P/E in the teens even as it’s one of the best stocks this decade. Time for a move up.

Where Do You Buy?

LinkedIn (LNKD) was $99 this quarter. It’s worth $77 next year and $128 the year after. Where do you buy? Hold out for the low-$90.

Where’s the Green?

Mastercard (MA) is losing its green. Quarterly growth has dipped below 20% and estimates show more of that ahead.

You Deserve a Rest

Take a break Catamaran (CTRX), you deserve a break after the 75% rise your stock’s had this year. Looking at estimates, it seems like another rise is on the horizon.

Continued Success

Portfolio Recovery Associates (PRAA) had another successful quarter, but the stock didn’t go up as it should have. I think this $100 stock is worth $150.

Earnings Miss Cools Down Hot Stock

Altisource Portfolio Solutions (ASPS) has been one of the hottest stocks of 12. ASPS just missed, that settled the stock down, but I still see ASPS going higher.

AMZN Continues to Build

Amazon.com (AMZN) continues to build new order fulfillment centers across the globe. That’s hurting profits now, but will help profits in the (far) future.

Trending Higher

Shares of Celgene (CELG) have been trending higher as of late. Backed by an all-green one-year chart, the trend is your friend.

Not a member? Sign up here for $25 a month.